Proof of Concept Treatment Study of Orally Administered VH4004280 or VH4011499 in HIV-1 Infected Adults

NCT06039579 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: VH4004280
DRUG: VH4011499
DRUG: VH4004280 Matching Placebo
DRUG: VH4011499 Matching Placebo
DRUG: Antiretroviral therapy

Sponsor

ViiV Healthcare